Šimečková et al., 1986 - Google Patents
The activity of complement in the presence of N-(2-hydroxypropyl) methacrylamide copolymersŠimečková et al., 1986
- Document ID
- 5841830343848531856
- Author
- Šimečková J
- Ríhová B
- Plocová D
- Kopecek J
- Publication year
- Publication venue
- Journal of Bioactive and Compatible Polymers
External Links
Snippet
This study indicates that N-(2-hydroxypropyl) methacrylamide homopolymers and copolymers containing oligopeptide sequences terminated in carboxylic acid groups, amine groups, aromatic units, or puromycin have no prominent effect on the porcine complement …
- 229920001577 copolymer 0 title abstract description 31
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Šimečková et al. | The activity of complement in the presence of N-(2-hydroxypropyl) methacrylamide copolymers | |
| CA1305053C (en) | Synthetic polymeric drugs | |
| Rihova et al. | Biocompatibility of N-(2-Hydroxypropyl) methacrylamide copolymers containing adriamycin: Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro | |
| Kopeček | Controlled biodegradability of polymers—a key to drug delivery systems | |
| Kopeček et al. | Polymers for colon-specific drug delivery | |
| Duncan et al. | Anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro | |
| US6310041B1 (en) | Synthetic complementary peptides and ophthalmologic uses thereof | |
| AU729026C (en) | Antiviral polymers comprising acid functional and hydrophobic groups | |
| EP0351987A1 (en) | Use of polymeric compounds in treatment | |
| EP0093489B1 (en) | Pharmaceutically active copolymers, process for their preparation and pharmaceutical compositions containing them | |
| Runnegar et al. | Isolation, characterization and pathology of the toxin from the blue-green alga Microcystis aeruginosa | |
| CA2072613C (en) | Iodothyronine polymers | |
| US20020107222A1 (en) | Modified polysaccharides for treatment of cancer | |
| Laki | Analytical Review: The Clotting of Fibrinogen | |
| EP0278416B1 (en) | Use of human blood coagulation factor xiii for the treatment of ulcerative colitis | |
| Šubr et al. | Degradation of oligopeptide sequences connecting poly [N-(2-hydroxypropyl) methacrylamide] chains by lysosomal cysteine proteinases | |
| Duncan et al. | Development of N-(2-hydroxypropyl) methacrylamide copolymers as carriers of therapeutic agents | |
| Volfova et al. | Biocompatibility of biopolymers | |
| Sintov et al. | Polymeric drug delivery of enzymatically degradable pendant agents: Peptidyl-linked procainamide model system studies | |
| US2843525A (en) | Insulin synthetic poly-amino acid complexes | |
| Sintov et al. | Enzymatic cleavage of disaccharide side groups in insoluble synthetic polymers: a new method for specific delivery of drugs to the colon | |
| Machovich et al. | Anticoagulant effect of sulphated poly/vinyl alcohol-acrylic acid/copolymers | |
| Etrych et al. | Release of polyanions from polyelectrolyte complexes by selective degradation of the polycation | |
| Wybran et al. | The rosetting factor of human mixed lymphocyte cultures | |
| CZ278551B6 (en) | Polymeric medicament, process for preparing thereof and pharmaceutical compositions based thereon |